Home About company history achievements our team Products Research Markets Contact News	Stephen T. Sonis, D.M.D., D.M.Sc. - Dr. Sonis is Professor of Oral Medicine, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine; Chief, Divisions of Oral Medicine, Brigham and Women's Hospital and the Dana-Farber Cancer Institute and Senior Surgeon, Brigham and Women's Hospital. After receiving his DMD from Tufts University, Dr. Sonis entered a combined doctorate and clinical specialty training program at Harvard University. Following completion of his degree and residency, he was awarded a Knox Fellowship to study tumor immunology at Oxford University. He returned to the United States to accept joint positions at the Peter Bent Brigham Hospital, Sidney Farber Cancer Center, and the Harvard School of Dental Medicine. Dr. Sonis' research has defined the biology and clinical significance of cancer regimen-related mucosal toxicities. Dr. Sonis' development of predictive animal models provided a means for him to investigate the biological basis of mucositis and to assist in the development of potential therapies. The results of his studies on the molecular and cellular pathogenesis of mucositis have established the basis of a mechanistic paradigm for mucosal injury, and have provided a number of treatment targets. Dr. Sonis has extensive experience in clinical trials for the prevention and treatment of mucosal barrier injury. In addition to his academic appointments, Dr. Sonis is the Chief Medical Consultant for Biomodels, LLC, a principle investigator of TRIAD Burden of Illness Studies, and a Special Government Employee of the FDA. Dr. Sonis has published extensively on the clinical, biological, and health economic aspects of oral complications of cancer therapy. He is the author of over 200 original publications, reviews and chapters, 7 books, and 5 patents. Dr. Sonis serves on a number of editorial boards, and is a founding member of the International Society of Oral Oncology and the International Academy of Oral Oncology.